The P53 tumor-suppressor gene is an advantageous tool for analyzing th
e molecular epidemiology of cancer. We describe the utility of the P53
gene as a 'mutagen test' and a prognostic indicator in breast cancer.
Aspects of study design and methodology are discussed Two major concl
usions emerge: (1) there is an extraordinary diversity of mutational p
atterns among coborts, hinting that the unique biology of mammary cell
s results in exposure to high doses of a diversity of ingested lipophi
lic mutagens; and (2) mutations in the P53 gene predict poor outcome i
n breast cancer.